The Impact of Medical Cannabis on Intermittent and Chronic Opioid Users with Back Pain: How Cannabis Diminished Prescription Opioid Usage.

To determine if cannabis may be used as an alternative or adjunct treatment for intermittent and chronic prescription opioid users. Retrospective cohort study. A single-center cannabis medical practice site in California. A total of 180 patients who had a chief complaint of low back pain were identified (, 10th Revision, code M54.5). Sixty-one patients who used prescription opioids were analyzed. Cannabis recommendations were provided to patients as a way to mitigate their low back pain. Number of patients who stopped opioids and change in morphine equivalents. There were no between-group differences based on demographic, experiential, or attitudinal variables. We found that 50.8% were able to stop all opioid usage, which took a median of 6.4 years (IQR=1.75-11 years) after excluding two patients who transitioned off opioids by utilizing opioid agonists. For those 29 patients (47.5%) who did not stop opioids, 9 (31%) were able to reduce opioid use, 3 (10%) held the same baseline, and 17 (59%) increased their usage. Forty-eight percent of patients subjectively felt like cannabis helped them mitigate their opioid intake but this sentiment did not predict who actually stopped opioid usage. There were no variables that predicted who stopped opioids, except that those who used higher doses of cannabis were more likely to stop, which suggests that some patients might be able to stop opioids by using cannabis, particularly those who are dosed at higher levels. In this long-term observational study, cannabis use worked as an alternative to prescription opioids in just over half of patients with low back pain and as an adjunct to diminish use in some chronic opioid users.